A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.
Clinical trial NCT06928363 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06928363
- Sponsor
- Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-11-12
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.